REG - Fevertree Drinks PLC - Transaction in Own Shares

Fevertree DrinksAnnouncement

Tue 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260602:nRSB4344Ga&default-theme=true

RNS Number : 4344G  Fevertree Drinks PLC  02 June 2026

2(nd) June 2026

Fevertree Drinks plc

("Fever-Tree" or the "Company")

Transaction in Own Shares

 

Fevertree Drinks plc ("Fever-Tree" or the "Company") announces today it has,
in accordance with the authority granted by shareholders at its 2025 Annual
General Meeting held on 5(th) June, purchased the following number of ordinary
shares of £0.0025 each in the Company (the "Ordinary Shares") through the
Company's broker, Investec Bank plc ("Investec") in the period from 25(th) May
to 29(th) May 2026.

 Date         Venue  Volume-weighted average price (p)  Aggregated volume            Lowest price per share (p)  Highest price per share (p)
 26 May 2026  XLON   787.7134                                      43,997            777.0000                    801.0000
 27 May 2026  XLON   805.9883                                      43,914            801.0000                    812.0000
 28 May 2026  XLON   797.7037                                      42,911            790.5000                    802.0000
 29 May 2026  XLON   781.1722                                      14,744            774.0000                    791.5000
 29 May 2026  AIMX   780.5000                                      10,000            780.5000                    780.5000

 

The Company intends to cancel the purchased shares.

 

Schedule of Purchases - Individual Transactions

In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market
Abuse Regulation) (which forms part of domestic UK law by virtue of the
European Union (Withdrawal) Act 2018, as amended), a full breakdown of the
individual trades made by Investec on behalf of the Company as part of the
share buyback programme is attached to this announcement.

 

http://www.rns-pdf.londonstockexchange.com/rns/4344G_1-2026-6-1.pdf
(http://www.rns-pdf.londonstockexchange.com/rns/4344G_1-2026-6-1.pdf)

 

This announcement does not constitute, or form part of, an offer or any
solicitation of an offer for securities in any jurisdiction.

 

For further information please contact:

 

Investor queries

Steve Nightingale, Director of Investor Relations I
steve.nightingale@fever-tree.com I +44 (0)7951 849564

 

Media queries

Oliver Winters, Director of Communications I oliver.winters@fever-tree.com I
+44 (0)770 332 9024

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  POSVFLBBQQLLBBX



            Copyright 2019 Regulatory News Service, all rights reserved